Sanofi Long-Term Concentrated

CIK: 0001121404 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $174,360 (100.0% shares, 0.0% debt)

Holdings (9)

MGTX MeiraGTx Holdings plc 42.6%

Value ($000) $74,284 Shares 12,197,737 Est. Cost $5.86 Unrealized 0.0%

NVAX Novavax 31.7%

Value ($000) $55,319 Shares 6,880,481 Est. Cost $9.64 Unrealized 0.0%

INBX Inhibrx Biosciences, Inc. 10.2%

Value ($000) $17,832 Shares 1,157,926 Est. Cost $15.23 Unrealized 0.0%

ANAB AnaptysBio 6.2%

Value ($000) $10,882 Shares 821,917 Est. Cost $24.22 Unrealized 0.0%

— IGM Biosciences 5.0%

Value ($000) $8,792 Shares 1,438,975 Est. Cost $6.11 Unrealized —

ELDN Eledon 1.9%

Value ($000) $3,358 Shares 814,980 Est. Cost $3.94 Unrealized 0.0%

— LAVA Therapeutics N.V. 1.0%

Value ($000) $1,825 Shares 1,919,455 Est. Cost $0.95 Unrealized —

— Inozyme, Inc 0.7%

Value ($000) $1,228 Shares 443,255 Est. Cost $2.77 Unrealized —

QTTB Q32 Bio Inc. 0.5%

Value ($000) $840 Shares 244,083 Est. Cost $31.58 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$74,284	42.6%	$5.86	0.0%	COM	G59665102
NVAX	Novavax	6,880,481	$55,319	31.7%	$9.64	0.0%	COM NEW	670002401
INBX	Inhibrx Biosciences, Inc.	1,157,926	$17,832	10.2%	$15.23	0.0%	COM	45720N103
ANAB	AnaptysBio	821,917	$10,882	6.2%	$24.22	0.0%	COM	032724106
—	IGM Biosciences	1,438,975	$8,792	5.0%	$6.11	—	COM	449585108
ELDN	Eledon	814,980	$3,358	1.9%	$3.94	0.0%	COM	28617K101
—	LAVA Therapeutics N.V.	1,919,455	$1,825	1.0%	$0.95	—	SHS	N51517105
—	Inozyme, Inc	443,255	$1,228	0.7%	$2.77	—	COM	45790W108
QTTB	Q32 Bio Inc.	244,083	$840	0.5%	$31.58	0.0%	COM	746964105